Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
5.31
+0.11 (2.12%)
At close: Mar 6, 2026, 4:00 PM EST
5.29
-0.02 (-0.38%)
After-hours: Mar 6, 2026, 4:10 PM EST
Verrica Pharmaceuticals Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Verrica Pharmaceuticals stock has a target of 17, which predicts an increase of 220.15% from the current stock price of 5.31.
Analyst Consensus: Buy
* Price targets were last updated on Dec 18, 2025.
Analyst Ratings
The average analyst rating for Verrica Pharmaceuticals stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Brookline Capital | Brookline Capital | Hold → Strong Buy Upgrades $17 | Hold → Strong Buy | Upgrades | $17 | +220.15% | Dec 18, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 14, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 8, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 12, 2025 |
Financial Forecast
Revenue This Year
35.78M
from 7.57M
Increased by 372.93%
Revenue Next Year
28.68M
from 35.78M
Decreased by -19.84%
EPS This Year
-1.56
from -14.78
EPS Next Year
-1.21
from -1.56
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 37.6M | 36.8M | ||||
| Avg | 35.8M | 28.7M | ||||
| Low | 33.8M | 19.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 396.8% | 2.7% | ||||
| Avg | 372.9% | -19.8% | ||||
| Low | 346.9% | -45.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.60 | -1.04 | ||||
| Avg | -1.56 | -1.21 | ||||
| Low | -2.07 | -1.50 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.